Skip to main content
Application Note

High-throughput- end-to-end Cell Free DNA -cfDNA- analysis workflow from plasma


Benefit of an automated cfDNA analysis workflow

The presence of double stranded, circulating cell free DNA (cfDNA) in blood plasma was discovered more than 70 years ago. Soon after, a link between cfDNA and leukemia as well as autoimmune disease was found.

Recently, the development of cfDNA-based prenatal genetic testing and the realization that cfDNA can be used to detect and monitor tumor specific mutations in cancer patients has increased the interest in cfDNA analyses.

Read the application note to review the results and how much time you could save by automating your cfDNA analysis workflow using Revvity’s automated solution including blood fractionation, cfDNA isolation, library prep, QC, and quantitation.

For research use only. Not for use in diagnostic procedures.

To view the full content please answer a few questions

By submitting my personal data, I acknowledge that Revvity Inc. and its affiliates (“Company”) will process my personal data provided above consistent with the Company’s Privacy Policy available here.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Download Resource

High-throughput- end-to-end Cell Free DNA -cfDNA- analysis workflow from plasma

Download Application Note